Stockreport

BrainStorm gets FDA okay for stem cell trial in MS patients [Reuters]

Brainstorm Cell Therapeutics Inc.  (BCLI) 
Last brainstorm cell therapeutics inc. earnings: 11/14 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.brainstorm-cell.com
PDF BrainStorm gets FDA okay for stem cell trial in MS patients | Reuters 2 Min Read TEL AVIV (Reuters) - BrainStorm Cell Therapeutics Inc has received approval from the U.S [Read more]